SOX2 and cancer: Furthermore, multiple studies in different types of stem cells or cancer cells have shown that repression of Sox2 transcription can be mediated directly by cell cycle effector genes or micro-RNAs [116–119], or by epigenetic modulations (i.e., phosphorylation, methylation, ubiquitination) that lead to Sox2 downregulation [120–124].